August 5, 2022
August 5, 2022 —
Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.
July 28, 2022
July 28, 2022 —
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
July 26, 2022
July 26, 2022 —
In a pair of related studies, UC San Diego researchers show that the origin of the COVID-19 pandemic was at a Chinese market and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.
July 21, 2022
July 21, 2022 —
UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.
July 20, 2022
July 20, 2022 —
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
June 23, 2022
June 23, 2022 —
A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
June 21, 2022
June 21, 2022 —
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
June 17, 2022
June 17, 2022 —
UC San Diego researchers report significant decrease in national cases of Kawasaki disease during COVID-19 pandemic; findings hint at origins of disease.
June 15, 2022
June 15, 2022 —
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.
May 16, 2022
May 16, 2022 —
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
